Serum cytokine elevations in celiac disease: Association with disease presentation

Human Immunology

Volumn 71, Issue 1, 2010, Pages 50-57

  Manavalan, John Sanil ^a   Hernandez, Lincoln ^a   Shah, Jayesh Girish ^a   Konikkara, John ^a   Naiyer, Afzal Jamal ^a   Lee, Anne Roland ^a   Ciaccio, Edward ^a   Minaya, Maria Theresa ^a   Green, Peter H R ^a   Bhagat, Govind ^a  

^a Columbia University ^*  (United States)

Author keywords

Celiac disease; Cytokines; TTg IgA antibodies

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY TITER; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GLUTEN FREE DIET; HUMAN; HUMAN TISSUE; IMMUNOASSAY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH2 CELL;

ADULT; CELIAC DISEASE; CYTOKINES; DIET, GLUTEN-FREE; HUMANS; IMMUNOGLOBULIN A; INTESTINE, SMALL; TRANSGLUTAMINASES;

EID: 71249096411     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.09.351     Document Type: Article

References (60)

1. Hernandez L., and Green P.H. Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep 8 (2006) 383-389
2. Gianfrani C., Auricchio S., and Troncone R. Adaptive and innate immune responses in celiac disease. Immunol Lett 99 (2005) 141-145
3. MacDonald T.T., and Spencer J. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med 167 (1988) 1341-1349
4. al-Dawoud A., Nakshabendi I., Foulis A., and Mowat A.M. Immunohistochemical analysis of mucosal gamma-interferon production in coeliac disease. Gut 33 (1992) 1482-1486
5. Cataldo F., Lio D., Marino V., Scola L., Crivello A., Corazza G.R., Working Group of the SIGEP, and Working Group of 'Club del Tenue'. Plasma cytokine profiles in patients with celiac disease and selective IgA deficiency. Pediatr Allerg Immunol 14 (2003) 320-324
6. Sollid L.M. Molecular basis of celiac disease. Annu Rev Immunol 18 (2000) 53-81
7. Nilsen E.M., Jahnsen F.L., Lundin K.E., Johansen F.E., Fausa O., and Sollid L.M. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 115 (1998) 551-563
8. Monteleone I., Monteleone G., Del Vecchio Blanco G., Vavassori P., Cucchiara S., MacDonald T.T., and Pallone F. Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa. Gut 53 (2004) 1090-1095
9. Hüe S., Mention J.J., Monteiro R.C., Zhang S., Cellier C., Schmitz J., et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21 (2004) 367-377
10. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T.N., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21 (2004) 357-366
11. Mauviel A. Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 53 (1993) 288-295
12. Graham M.F., Willey A., Adams J., Yager D., and Diegelmann R.F. Interleukin 1beta downregulates collagen and augments collagenase expression in human intestinal smooth muscle cells. Gastroenterology 110 (1996) 344-350
13. Daum S., Bauer U., Foss H.D., Schuppan D., Stein H., Riecken E.O., and Ullrich R. Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 44 (1999) 17-25
14. Kontakou M., Sturgess R.P., Przemioslo R.T., Limb G.A., Nelufer J.M., and Ciclitira P.J. Detection of interferon gamma mRNA in the mucosa of patients with coeliac disease by in situ hybridisation. Gut 35 (1994) 1037-1041
15. Przemioslo R.T., Kontakou M., Nobili V., and Ciclitira P.J. Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry. Gut 35 (1994) 1398-1403
16. Kontakou M., Przemioslo R.T., Sturgess R.P., Limb G.A., Ellis H.J., Day P., and Ciclitira P.J. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge. Gut 37 (1995) 52-57
17. Beckett C.G., Dell'Olio D., Kontakou M., Przemioslo R.T., Rosen-Bronson S., and Ciclitira P.J. Analysis of interleukin-4 and interleukin-10 and their association with the lymphocytic infiltrate in the small intestine of patients with coeliac disease. Gut 39 (1996) 818-823
18. Chowers Y., Marsh M.N., De Grandpre L., Nyberg A., Theofilopoulos A.N., and Kagnoff M.F. Increased proinflammatory cytokine gene expression in the colonic mucosa of coeliac disease patients in the early period after gluten challenge. Clin Exp Immunol 107 (1997) 141-147
19. + T lymphocytes. Immunology 86 (1995) 104-109
20. Westerholm-Ormio M., Garioch J., Ketola I., and Savilahti E. Inflammatory cytokines in small intestinal mucosa of patients with potential coeliac disease. Clin Exp Immunol 128 (2002) 94-101
21. Penedo-Pita M., and Peteiro-Cartelle J. Increased serum levels of interleukin-2 and soluble interleukin-2 receptor in celiac disease. J Pediatr Gastroenterol Nutr 12 (1991) 56-60
22. Blanco A., Garrote J.A., Arranz E., Alonso M., and Clavo C. Increased serum IL-2R levels in coeliac disease are related to CD4 but not CD8 antigens. J Pediatr Gastroenterol Nutr 15 (1992) 413-417
23. Cataldo F., and Marino V. Increased prevalence of autoimmune diseases in first-degree relatives of patients with celiac disease. J Pediatr Gastroenterol Nutr 36 (2003) 470-473
24. Lahat N., Shapiro S., Karban A., Gerstein R., Kinarty A., and Lerner A. Cytokine profile in coeliac disease. Scand J Immunol 49 (1999) 441-446
25. Cinova J., Palová-Jelínková L., Smythies L.E., Cerná M., Pecharová B., Dvorák M., et al. Gliadin peptides activate blood monocytes from patients with celiac disease. J Clin Immunol 27 (2007) 201-209
26. h2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 166 (1987) 1229-1244
27. Karban A., Lerner A., and Shapiro S. TH1/TH2 cytokine profile in celiac disease. Isr J Med Sci 33 (1997) 209-214
28. Oberhuber G., Granditsch G., and Vogelsang H. The histopathology of coeliac disease: Time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 11 (1999) 1185-1194
29. Dieterich W., Ehnis T., Bauer M., Donner P., Volta U., Riecken E.O., and Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3 (1997) 797-801
30. Marsh M.N. Mucosal pathology in gluten sensitivity. In: Marsh M.N. (Ed). Coeliac disease (1992), Blackwell Scientific Publications, Oxford 136-191
31. Fornari M.C., Pedreira S., Niveloni S., González D., Diez R.A., Vázquez H., et al. Pre- and post-treatment serum levels of cytokines IL-1beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia?. Am J Gastroenterol 93 (1998) 413-418
32. Nilsen E.M., Gjertsen H.A., Jensen K., Brandtzaeg P., and Lundin K.E. Gluten activation of peripheral blood T cells induces a Th0-like cytokine pattern in both coeliac patients and controls. Clin Exp Immunol 103 (1996) 295-303
33. Lio D., Bonanno C.T., D'Anna C., De Luca S., Gervasi F., Cavataio F., et al. Gluten stimulation induces an in vitro expansion of peripheral blood T gamma delta cells from HLA-DQ2-positive subjects of families of patients with celiac disease. Exp Clin Immunogenet 15 (1998) 46-55
34. Stepniak D., and Koning F. Celiac disease-sandwiched between innate and adaptive immunity. Hum Immunol 67 (2006) 460-468
35. Wapenaar M.C., van Belzen M.J., Fransen J.H., Sarasqueta A.F., Houwen R.H., Meijer J.W., et al. The interferon gamma gene in celiac disease: Augmented expression correlates with tissue damage but no evidence for genetic susceptibility. J Autoimmun 23 (2004) 183-190
36. Mention J.J., Ben Ahmed M., Bègue B., Barbe U., Verkarre V., Asnafi V., et al. Interleukin 15: A key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125 (2003) 730-745
37. Gordon J. CD23 and B cell activation. Clin Exp Allerg 22 (1992) 199-204
38. Snapper C.M., Finkelman F.D., and Paul W.E. Regulation of IgG1 and IgE production by interleukin 4. Immunol Rev 102 (1988) 51-75
39. Forsberg G., Hernell O., Melgar S., Israelsson A., Hammarström S., and Hammarström M.L. Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease. Gastroenterology 123 (2002) 667-678
40. Mizrachi A., Broide E., Buchs A., Kornberg A., Aharoni D., Bistritzer T., and Rapoport M.J. Lack of correlation between disease activity and decreased stimulated secretion of IL-10 in lymphocytes from patients with celiac disease. Scand J Gastroenterol 37 (2002) 924-930
41. Forsberg G., Hernell O., Hammarström S., and Hammarström M.L. Concomitant increase of IL-10 and pro-inflammatory cytokines in intraepithelial lymphocyte subsets in celiac disease. Int Immunol 19 (2007) 993-1001
42. León F., Sánchez L., Camarero C., and Roy G. Cytokine production by intestinal intraepithelial lymphocyte subsets in celiac disease. Dig Dis Sci 50 (2005) 593-600
43. Kolkowski E.C., Fernández M.A., Pujol-Borrell R., and Jaraquemada D. Human intestinal alphabeta IEL clones in celiac disease show reduced IL-10 synthesis and enhanced IL-2 production. Cell Immunol 244 (2006) 1-9
44. Dinarello C.A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Internation Rev Immunol 16 (1998) 457-499
45. Palová-Jelínková L., Rozková D., Pecharová B., Bártová J., Sedivá A., Tlaskalová-Hogenová H., et al. Gliadin fragments induce phenotypic and functional maturation of human dendritic cells. J Immunol 175 (2005) 7038-7045
46. Murphy P.M. Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin Hematol 34 (1997) 311-318
47. Hall III R.P., Benbenisty K.M., Mickle C., Takeuchi F., and Streilein R.D. Serum IL-8 in patients with dermatitis herpetiformis is produced in response to dietary gluten. J Invest Dermatol 127 (2007) 2158-2165
48. Mitsuyama K., Sata M., and Rose-John S. Interleukin-6 trans-signaling in inflammatory bowel disease. Cytokine Growth Factor Rev 17 (2006) 451-461
49. Romaldini C.C., Barbieri D., Okay T.S., Raiz Jr. R., and Cançado E.L. Serum soluble interleukin-2 receptor, interleukin-6, and tumor necrosis factor-alpha levels in children with celiac disease: Response to treatment. J Pediatr Gastroenterol Nutr 35 (2002) 513-517
50. Sulkanen S., Halttunen T., Laurila K., Kolho K.L., Korponay-Szabó I.R., and Sarnesto A. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115 (1998) 1322-1328
51. Dieterich W., Laag E., Schöpper H., Volta U., Ferguson A., and Gillett H. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115 (1998) 1317-1321
52. Seissler J., Boms S., Wohlrab U., Morgenthaler N.G., Mothes T., Boehm B.O., and Scherbaum W.A. Antibodies to human recombinant tissue transglutaminase measured by radioligand assay: Evidence for high diagnostic sensitivity for celiac disease. Horm Metab Res 31 (1999) 375-379
53. Bazzigaluppi E., Lampasona V., Barera G., Venerando A., Bianchi C., Chiumello G., et al. Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease. J Autoimmun 12 (1999) 51-56
54. Picarelli A., di Tola M., Sabbatella L., Mastracchio A., Trecca A., Gabrielli F., et al. Identification of a new coeliac disease subgroup: Antiendomysial and anti-transglutaminase antibodies of IgG class in the absence of selective IgA deficiency. J Intern Med 249 (2001) 181-188
55. Schultz C.L., and Coffman R.L. Control of isotype switching by T cells and cytokines. Curr Opin Immunol 3 (1991) 350-354
56. Rostami K., Kerckhaert J., Tiemessen R., von Blomberg B.M., Meijer J.W., and Mulder C.J. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: Disappointing in clinical practice. Am J Gastroenterol 94 (1999) 888-894
57. Abrams J.A., Diamond B., Rotterdam H., and Green P.H. Seronegative celiac disease: Increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci 49 (2004) 546-550
58. Abrams J.A., Brar P., Diamond B., Rotterdam H., and Green P.H. Utility in clinical practice of immunoglobulin A anti-tissue transglutaminase antibody for the diagnosis of celiac disease. Clin Gastroenterol Hepatol 4 (2006) 726-730
59. Fasano A., and Catassi C. Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum. Gastroenterology 120 (2001) 636-651
60. Pynnönen P., Isometsä E., Aalberg V., Verkasalo M., and Savilahti E. Is coeliac disease prevalent among adolescent psychiatric patients?. Acta Paediatr 91 (2002) 657-659